CHICAGO, IL—Chlorthalidone does not reduce major adverse cardiovascular events compared hydrochlorothiazide in older, predominantly male military veterans with hypertension, according to the ...
In 2020, Part D Medicare expenditures showed that approximately 1.5 million persons received prescriptions for chlorthalidone as compared with 11.5 million who received prescriptions for ...
Preferred diuretic option now accessible in guideline-recommended 12.5 mg dose for U.S. patients. Chlorthalidone, a thiazide-like diuretic, has played a central role in hypertension management for ...
BOSTON -- In people with hypertension, a history of kidney stones may inform the choice of diuretic for stone prevention, according to a secondary analysis of the Diuretic Comparison Project. Among ...
The Diuretic Comparison Project (DCP) trial, showing no difference in reduction of clinical events between the thiazide diuretics chlorthalidone and hydrochlorothiazide when used for the treatment of ...
WEST CONSHOHOCKEN, Pa., Nov. 7, 2025 /PRNewswire/ -- PRM Pharma, LLC announces the nationwide availability of HemiClor® (chlorthalidone) 12.5 mg tablets, the first and only FDA-approved 12.5 mg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results